Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J D Spahn"'
Publikováno v:
The Journal of Immunology. 157:2654-2659
We have recently demonstrated that the combination of IL-2 and IL-4 blunts T cell responses to glucocorticoids in steroid resistant (SR) asthma by reducing glucocorticoid receptor (GCR)-binding affinity. Since immune activation appears to be involved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee134b6f4cce2ba3cbf8f50cdd65bd09
https://doi.org/10.4049/jimmunol.157.6.2654
https://doi.org/10.4049/jimmunol.157.6.2654
Autor:
R F, Lemanske, C A, Sorkness, E A, Mauger, S C, Lazarus, H A, Boushey, J V, Fahy, J M, Drazen, V M, Chinchilli, T, Craig, J E, Fish, J G, Ford, E, Israel, M, Kraft, R J, Martin, S A, Nachman, S P, Peters, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy.To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta(2)-agonist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b8c95dcb18989d7189179f3b7b52c69
https://pubmed.ncbi.nlm.nih.gov/11829556
https://pubmed.ncbi.nlm.nih.gov/11829556
Autor:
S C, Lazarus, H A, Boushey, J V, Fahy, V M, Chinchilli, R F, Lemanske, C A, Sorkness, M, Kraft, J E, Fish, S P, Peters, T, Craig, J M, Drazen, J G, Ford, E, Israel, R J, Martin, E A, Mauger, S A, Nachman, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Long-acting beta(2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma.To examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::545c6bd94a5258736cb9bb36502e8708
https://pubmed.ncbi.nlm.nih.gov/11829555
https://pubmed.ncbi.nlm.nih.gov/11829555
Publikováno v:
The American journal of physiology. 266(1 Pt 1)
The expression of cytocidal activity is initiated by the interaction of macrophages with priming [e.g., interferon (IFN)] and triggering stimuli (polyinosinic-polycytidylic acid). We have shown that the triggering step can be initiated in a Ca(2+)-de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3258171938418f30716b9551ce0a0a2
https://pubmed.ncbi.nlm.nih.gov/8304411
https://pubmed.ncbi.nlm.nih.gov/8304411
Autor:
Langemo D; Diane Langemo, PhD, RN, FAAN, is President, Langemo & Associates, and Adjunct Professor, University of North Dakota, Grand Forks, North Dakota. James G. Spahn, MD, FACS, is Founder, Chairman of the Board, and Chief Executive Officer, WoundVision LLC; and Founder, Chairman of the Board, EHOB Inc, Indianapolis, Indiana. Dr Langemo has disclosed that she is a consultatnt to WoundVision; received payment for manuscript writing from WoundVision; received payment for expert testimony from multiple US law firms; and has received grant money from DermaSciences. Dr Spahn has disclosed that he is the managing partner and owner of WoundVision, LLC, and Chief Executive Officer and board member and employee of EHOB, Inc; his brother, Tom Spahn, MD, is an employee of WoundVision, LLC; and his son, J. D. Spahn, is a partner and owner of WoundVision, LLC. Submitted May 27, 2015; accepted in revised form November 12, 2015., Spahn JG
Publikováno v:
Advances in skin & wound care [Adv Skin Wound Care] 2016 Apr; Vol. 29 (4), pp. 155-63.